Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

184 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
In vitro Cytokine Responses to Virulent PRRS Virus Strains.
Ferlazzo G, Ruggeri J, Boniotti MB, Guarneri F, Barbieri I, Tonni M, Bertasio C, Alborali GL, Amadori M. Ferlazzo G, et al. Front Vet Sci. 2020 Jul 15;7:335. doi: 10.3389/fvets.2020.00335. eCollection 2020. Front Vet Sci. 2020. PMID: 32760741 Free PMC article.
Characterization of the IgA response to PRRS virus in pig oral fluids.
Ruggeri J, Ferlazzo G, Boniotti MB, Capucci L, Guarneri F, Barbieri I, Alborali GL, Amadori M. Ruggeri J, et al. Among authors: ferlazzo g. PLoS One. 2020 Mar 3;15(3):e0229065. doi: 10.1371/journal.pone.0229065. eCollection 2020. PLoS One. 2020. PMID: 32126095 Free PMC article.
Correction: Ambulatory management of pre- and extensively drug resistant tuberculosis patients with imipenem delivered through port-a-cath: A mixed methods study on treatment outcomes and challenges.
Chavan VV, Dalal A, Nagaraja S, Thekkur P, Mansoor H, Meneguim A, Paryani R, Singh P, Kalon S, Das M, Ferlazzo G, Isaakidis P. Chavan VV, et al. Among authors: ferlazzo g. PLoS One. 2024 Feb 21;19(2):e0299477. doi: 10.1371/journal.pone.0299477. eCollection 2024. PLoS One. 2024. PMID: 38381762 Free PMC article.
Management of rifampicin-resistant tuberculosis in conflict-affected areas: The case of Iraq.
Tesfahun HM, Al-Salihi L, Abdulkareem Al-Ani N, Mankhi AA, Mohammed A, Lim CAE, Al-Hilfi RA, Jouego CG, Decroo T, Moussally K, Ferlazzo G, Isaakidis P. Tesfahun HM, et al. Among authors: ferlazzo g. PLoS One. 2024 Jan 19;19(1):e0296952. doi: 10.1371/journal.pone.0296952. eCollection 2024. PLoS One. 2024. PMID: 38241233 Free PMC article.
Evaluating newly approved drugs in combination regimens for multidrug-resistant tuberculosis with fluoroquinolone resistance (endTB-Q): study protocol for a multi-country randomized controlled trial.
Patil SB, Tamirat M, Khazhidinov K, Ardizzoni E, Atger M, Austin A, Baudin E, Bekhit M, Bektasov S, Berikova E, Bonnet M, Caboclo R, Chaudhry M, Chavan V, Cloez S, Coit J, Coutisson S, Dakenova Z, De Jong BC, Delifer C, Demaisons S, Do JM, Dos Santos Tozzi D, Ducher V, Ferlazzo G, Gouillou M, Khan U, Kunda M, Lachenal N, LaHood AN, Lecca L, Mazmanian M, McIlleron H, Moreau M, Moschioni M, Nahid P, Osso E, Oyewusi L, Panda S, Pâquet A, Thuong Huu P, Pichon L, Rich ML, Rupasinghe P, Salahuddin N, Sanchez Garavito E, Seung KJ, Velásquez GE, Vallet M, Varaine F, Yuya-Septoh FJ, Mitnick CD, Guglielmetti L. Patil SB, et al. Among authors: ferlazzo g. Trials. 2023 Nov 30;24(1):773. doi: 10.1186/s13063-023-07701-6. Trials. 2023. PMID: 38037119 Free PMC article.
Potential predictive role of gut microbiota to immunotherapy in HCC patients: a brief review.
Muscolino P, Granata B, Omero F, De Pasquale C, Campana S, Calabrò A, D'Anna F, Drommi F, Pezzino G, Cavaliere R, Ferlazzo G, Silvestris N, Speranza D. Muscolino P, et al. Among authors: ferlazzo g. Front Oncol. 2023 Aug 25;13:1247614. doi: 10.3389/fonc.2023.1247614. eCollection 2023. Front Oncol. 2023. PMID: 37692859 Free PMC article. Review.
184 results